Popis: |
Zehuai Wen,1 Jia Wei,2 Huiling Xue,2 Yunqin Chen,2 David Melnick,3 Jesus Gonzalez,4 Judith Hackett,5 Xiaoyan Li,1 Zhaolong Cao6 1Key Unit of Methodology in Clinical Research, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, 2AstraZeneca R&D Information China, Shanghai, China; 3Anti-Infectives Actavis, Inc. Harborside Financial Center, Jersey City, NJ, USA; 4AstraZeneca, Manchester, UK; 5AstraZeneca, Gaithersburg, MD, USA; 6Peking University People’s Hospital, Beijing, China Background: The etiology, epidemiology, treatment patterns, and clinical outcomes of neonatal and pediatric pneumonia patients in China are not well reported. This retrospective chart review study aimed to describe such information among neonatal (0 to 27 days) and pediatric (28 days to |